Effect of the COVID-19 pandemic on antibiotic use in primary care

  03 February 2021

During the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), disruption of antimicrobial stewardship interventions has become a matter of concern. Antimicrobial resistance and the many unintended negative clinical consequences resulting from antibiotic misuse and overuse will persist and may potentially be aggravated by the pandemic, making it necessary to measure its impact on antibiotic use in all healthcare settings.

Antibiotic consumption increased in hospitals during the pandemic; however, no study has reported the effect on antibiotic use in the community. Our objective was to assess the impact of the COVID-19 pandemic on antibiotic prescribing in primary care in a region with an existing comprehensive antimicrobial stewardship programme (ASP) for hospitals and primary care centres, the PIRASOA programme.

Author(s): Germán Peñalva, PhD Regina Sandra Benavente, PharmD María Antonia Pérez-Moreno, PhD María Dolores Pérez-Pacheco, PharmD Alejandro Pérez-Milena, PhD José Murcia, PhD José Miguel Cisneros, MD, PhD
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!